Risk Of Severe Hepatic Injury In Patients With Invasive Candidiasis Treated With Echinocandins
Stopped The study was terminated on May 5, 2011, due to methodological issues. The decision to terminate the study was not based on any safety or efficacy concerns.
Conditions
- Invasive Candidiasis
- Candidemia
Interventions
- OTHER: Does not apply
- OTHER: Does not apply
Sponsor
Pfizer